Wellcome Photography Prize 2025: Winning Images Reveal Powerful Stories of Science and Health
Sujata Setia, Mithail Afrige Chowdhury and Steve Gschmeissner awarded £10,000 each for images exploring domestic abuse, climate migration and the...
Disability
Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study
– Peer-reviewed publication in Annals of Clinical and Translational Neurology highlights the use of the MSA Atrophy Index developed to...
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum with 7% growth (CER) in the first half of 2025
Basel, 24 July 2025 Group sales grew by 7%1 at constant exchange rates (CER; 4% in CHF), driven by strong...
AnswersNow Launches Corporate Advisory Board to Advance Scale of Innovative Virtual Autism Platform
Board brings together diverse industry veterans representing insurers, educators, clinicians and healthcare providers to ensure a robust, practical approach to...
ProMIS Neurosciences Granted Fast Track Designation by U.S. FDA for PMN310 in the Treatment of Alzheimer’s Disease
FDA designation highlights the potential of PMN310 to deliver a more targeted approach to treating Alzheimer’s DiseaseCAMBRIDGE, Mass., July 21,...
ProMIS Neurosciences Granted Fast Track Designation by U.S. FDA for PMN310 in the Treatment of Alzheimer’s Disease
FDA designation highlights the potential of PMN310 to deliver a more targeted approach to treating Alzheimer’s Disease CAMBRIDGE, Mass., July...
George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US
George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US...
Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation
NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering...
Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial
Company also announces new 500-patient SUMMIT RISE study at the Society of NeuroInterventional Surgery annual meetingSAN MATEO, Calif., July 14,...
Access Ready Strategic Joins the American Association of People With Disabilities (AAPD) and the Consortium for Constituents with Disabilities (CCD) Along with Other Organizations on Vital Policy and Public Interest Positions
Many Groups and Organizations respond to Policy Issues WASHINGTON, July 10, 2025 /PRNewswire/ -- The recent rapid approach to policy...
Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress
– Data from an analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed improvements...
Qanatpharma, Zuse Institute Berlin, Enamine, and Proteros biostructures Announce Generative-AI Driven Lead Discovery Collaboration
Joint research program targets new treatments for life-threatening complication of brain hemorrhage An international discovery collaboration is harnessing AI-powered drug...
Morgan AH Medical Unveils Patented Rolling Expandable Bathtub at Abilities Expo Chicago – Hailed as a “Game Changer” for Accessible Bathing
Chicago, Illinois--(Newsfile Corp. - July 3, 2025) - Morgan AH Medical made headlines at this year's Abilities Expo Chicago (June...
IDMC Provides Positive Recommendation for Bio-Thera Solution’s BAT4406F (ADCC-Enhanced Anti-CD20 mAb) in Neuromyelitis Optica Spectrum Disorder Based on Interim Analysis of Pivotal Phase II/III Trial
GUANGZHOU, China, July 2, 2025 /PRNewswire/ -- Bio-Thera Solutions, Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative...
Make Summer as Safe as It is Fun
MISSION, Kan., June 30, 2025 /PRNewswire/ -- (Family Features) With school out for summer, children will be away from teachers...
Dearborn Group and Symetra Reach Agreement on Acquisition of Dearborn Group’s Life & Disability Business
Dearborn Group shifts focus to core health offerings as Symetra adds scale to growing Workforce Benefits business Symetra to become...
Baylor Genetics Applauds New Guidance from American Academy of Pediatrics for Genome and Exome Sequencing to be used as First-Tier Tests for Children with Certain Developmental Delays
Guidance also outlines metabolic evaluation – like Baylor Genetics’ unique Global MAPS® untargeted metabolite screen – as second-tier testHOUSTON, June...
Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results
Salanersen (BIIB115/ION306) is a novel antisense oligonucleotide (ASO) with the potential to achieve high efficacy and once yearly dosing in...
Empo Health® Raises $7M to Launch a Category-leading System for Remote Diabetic Foot Ulcer (DFU) Management
New funding supports market launch of Empo's pioneering at-home monitoring system to help prevent diabetic amputations and reduce healthcare costs...
Major Disability Care Provider Initiates On-Premise Deployment
(CSE: PPB / FSE: 3QG / US: PPBGF)investor@p2p-group.com Highlights: Evaluation deployment originated by a major provider from inbound demand and...